Amicus Therapeutics, Inc.
(NASDAQ : FOLD)

( )
FOLD After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.88%93.921.3%$988.55m
BIIBBiogen Inc.
2.45%229.891.3%$619.18m
AMGNAmgen Inc.
1.22%180.481.3%$474.61m
GILDGilead Sciences, Inc.
2.13%64.140.9%$448.87m
ILMNIllumina, Inc.
1.49%319.203.5%$295.43m
REGNRegeneron Pharmaceuticals, Inc.
2.80%349.992.6%$291.08m
VRTXVertex Pharmaceuticals Incorporated
1.18%174.611.9%$236.35m
ALXNAlexion Pharmaceuticals, Inc.
4.30%135.682.0%$176.60m
EXASExact Sciences Corporation
0.27%95.3925.3%$169.11m
AAgilent Technologies, Inc.
1.23%76.721.6%$147.38m
SRPTSarepta Therapeutics, Inc.
1.74%120.2214.7%$129.47m
ONCESpark Therapeutics, Inc.
0.64%111.3811.2%$116.56m
INCYIncyte Corporation
0.57%73.942.5%$97.68m
IONSIonis Pharmaceuticals, Inc.
0.72%73.868.3%$96.82m
BMRNBioMarin Pharmaceutical Inc.
-0.21%85.314.3%$92.88m

Company Profile

Amicus Therapeutics, Inc. engages in the discovery, developmen0t, and commercialization of novel treatments for patients living with rare and orphan diseases. Its product include migalastat HCl, which is a small molecule that can be used as a monotherapy and in combination with enzyme replacement therapy for fabry disease. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ.